CClinicalTrials.gg
CompletedNCT07405632HECOGUpdated Feb 12, 2026

The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cognitive Functioning

An interventional study of Hericium erinaceus Supplementation and Placebo in Attention, Memory and Cognitive Function and Well-Being, sponsored by University of Social Sciences and Humanities, Warsaw. Completed at 1 site in Poland. Open to female participants aged 30 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by University of Social Sciences and Humanities, Warsaw · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jan 2025, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
85
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
Female
01

Study summary

The goal of this study is to determine whether supplementation with Hericium erinaceus (Lion's Mane) extract enhances selected cognitive functions in healthy, actively working, middle-aged women. We aim to investigate a broad spectrum of cognitive functions to identify which, if any, are affected both immediately and after prolonged supplementation with Hericium erinaceus extract.

Our main research questions are as follows:

  1. Can Hericium erinaceus extract supplementation modify cognitive status?
  2. Is there an immediate effect on cognition following a single intake of Hericium erinaceus extract?
  3. Does prolonged supplementation with Hericium erinaceus extract influence cognitive functioning?
  4. Which cognitive functions are affected, and will the patterns differ between immediate effects and those observed after long-term supplementation?
  5. Will participants report subjective cognitive enhancement?

Our main hypotheses are as follows:

  1. A single dose of Hericium erinaceus extract will produce an acute effect, improving attention 45 minutes after intake.
  2. An eight-week supplementation period with Hericium erinaceus extract will produce a chronic effect, improving long-term memory.
  3. The investigators will compare Hericium erinaceus extract with a placebo (a visually identical substance that contains no active ingredients) to determine whether the extract effectively enhances cognitive functioning.

Participants will:

  1. Take a Hericium erinaceus extract or placebo capsule daily for 2 months.
  2. Visit SWPS University for baseline assessments before beginning supplementation (T0), a follow-up assessment 45 minutes after the initial intake (T1), and additional assessments at 1 week (T2) and 2 months (T3).
  3. Complete neuropsychological testing and questionnaires during the T1, T2, and T3 visits.
  4. Maintain their usual dietary habits throughout the study.
02

Conditions studied

  • Attention
  • Memory
  • Cognitive Function and Well-Being

Keywords

  • Lion's Mane
  • Hericium erinaceus
  • Cognitive functioning
  • Attention
  • Well-being
03

In context

Lead sponsor

University of Social Sciences and Humanities, Warsaw is the lead sponsor of 24 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

- residing in Warsaw, Poland or the surrounding area.

Exclusion criteria

Exclusion Criteria:

  • pregnancy or lactation,
  • history of head injury with neurological consequences,
  • history of neurological disorders or diseases,
  • chronic use of antibiotics,
  • use of antibiotics within the last 30 days,
  • chronic use of antifungal medications,
  • use of antifungal medications within the last 30 days,
  • allergies or intolerance to mushrooms (especially Lion's Mane),
  • consumption of caffeinated beverages (e.g., coffee, energy drinks) prior to the study visit.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
85 participants (actual)

Study arms

  • Experimental
    Hericium erinaceu

    This is a group of participants who will receive Hericium erinaceu during the duration of the study.

    Dietary Supplement: Hericium erinaceus Supplementation

  • Placebo comparator
    Placebo

    This is a group of participants who will receive placebo during the wole duration of the study.

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementHericium erinaceus Supplementation

    Each participant will take extract from the fruiting bodies of Lion's Mane mushroom (Hericium erinaceus; trade name: Lion's Mane Focus; manufacturer: Omyu sp. z o.o., Warsaw, Poland). Composition: mineral water, food-grade ethanol \<22%, dried Lion's Mane fruiting bodies 20,000 mg. \* Dosage: 1ml per day\*. \* Instructions: Take before 1:00 PM.\*

  • Dietary supplementPlacebo

    Each participant will take placebo. Composition: mineral water, food-grade ethanol \<22%, caramel food flavouring 0.2%. \* Dosage: 1ml per day\*. \* Instructions: Take before 1:00 PM.\*

06

What researchers measure

Primary outcomes

  1. Change in d' score in old/new recognition test (ONR) to assess long-term memory

    The old/new word recognition task is designed to assess episodic memory. It is consisted of two phases: a learning phase and a recognition phase. During the learning phase, participants viewed 30 pictures on the computer. In the recognition phase, participants were presented with 30 "old" and 30 "new" pictures in random order and were asked to determine whether each picture had been shown during the learning phase. To analyze episodic memory task we followed Macmillan and Creelman (2005) signal detection theory, where d' is the ability to discriminate between signal and noise (between old and new stimuli), H stands for the proportion of correct changes detected (hit rate), and F stands for the proportion of changes incorrectly reported (false alarm rate). d' = zH - zF

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  2. Change in Differentiation score in California Verbal Learning Test (CVLT) to assess long-term memory

    California Verbal Learning Test (CVLT) measure the verbal learning and memory. It measures how well individuals learn and recall verbal material, assessing both short-term and long-term memory. The Differentiation score measures the ability to distinguish between correct and incorrect responses. Scores range from 0 to 16, with higher scores indicating better outcome.

    Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  3. Change in Concentration score in d2 Test of Attention (d2-R) - to assess attention

    Scores range from 0 to 308, with higher scores indicating better outcome.

    Time frame: 45 minutes after the first dose, and at 8 week after the start of supplementation with Hericium erinaceus extract or placebo.

  4. Change in the number of correctly marked target characters in the d2 Test of Attention (d2-R) - to assess attention.

    Scores range from 0 to 308, with higher scores indicating better outcome.

    Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  5. Change in cueing effect in the Posner Cueing Task to assess attentional orienting efficiency

    The Posner Cueing Task assesses visuospatial selective attention, specifically the speed and efficiency of orienting attention to a cued location. To analyze this efficiency, we calculated the cueing effect. This is defined as the difference in mean reaction time between invalidly cued trials and validly cued trials (RT invalid-RT valid). A larger cueing effect indicates a higher "cost" of disengaging attention from an incorrect location and shifting it to the correct target.

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  6. Change in reaction time to validly cued targets in the Posner Cueing Task to assess attentional orienting speed

    The Posner Cueing Task assesses visuospatial selective attention, specifically the speed and efficiency of orienting attention to a cued location. To assess attentional orienting speed, the primary outcome is the reaction time to the target in valid trials (where the cue correctly predicts the target location). A shorter reaction time indicates faster attentional orienting to the predicted spatial location. Reaction times are measured in milliseconds.

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

Secondary outcomes

  1. Changes in Beck Depression Inventory (BDI) total score to assess symptoms of depression

    Scores range from 0 to 63, with higher scores indicating more severe depressive symptoms.

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  2. Changes in the Fatigue Assessment Scale (FAS) total score to assess symptoms of chronic fatigue

    Scores range from 10 to 50, with higher scores indicating greater fatigue.

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  3. Change in Color Trails Test (CTT) completion time - CTT1 to assess several attention and executive functions especially perceptual tracking, sustained and divided attention

    A maximum time limit of 240 seconds (4 minutes) is applied.

    Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  4. Change in Color Trails Test (CTT) completion time - CTT2 to assess several attention and executive functions especially perceptual tracking, sustained and divided attention

    A maximum time limit of 240 seconds (4 minutes) is applied.

    Time frame: 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  5. Change in Wechsler Adult Intelligence Scale (WAIS) Digit Span Forward subset total score to assess short-term auditory memory

    Scores range from 0 to 14, with higher scores indicating better outcome.

    Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  6. Change in Wechsler Adult Intelligence Scale (WAIS) Digit Span Backward subset total score to assess short-term auditory memory

    Scores range from 0 to 14, with higher scores indicating better outcome.

    Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  7. Change in Wechsler Adult Intelligence Scale (WAIS) Digit Symbol Substitution subtest total score to assess cognitive processing speed, visual-motor coordination, and sustained attention

    Scores range from 0 to 39, with higher scores indicating better outcome.

    Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  8. Changes in Memory Functioning Questionnaire (MFQ) total score

    The Memory Functioning Questionnaire (MFQ) is a self-report instrument designed to assess subjective memory functioning and memory complaints. We utilized the version developed by Gilewski et al. (1990), which consists of 64 items divided into four main subscales: Frequency of Forgetting, Seriousness of Forgetting, Retrospective Functioning, and Mnemonics Usage. Higher scores on the MFQ indicate a higher level of perceived memory functioning.

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  9. Change in Operation Span (OSPAN) capacity load to assess working memory capacity

    The Operation Span (OSPAN) task is a standard measure of working memory capacity, requiring participants to solve mathematical equations while simultaneously remembering a sequence of letters. The primary outcome measure is the capacity load, which represents the sum of all letters from sets that were recalled perfectly in their correct order. A higher capacity load score indicates a greater ability to maintain and manipulate information in the face of distraction, reflecting superior working memory capacity.

    Time frame: 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

  10. Change in energy scores

    Scores range from 0 to 100, with higher scores indicating higher subjective energy at the time of assessment.

    Time frame: Baseline (prior to intervention), 45 minutes after the first dose, and at 1 week and 8 weeks after the start of supplementation with Hericium erinaceus extract or placebo.

Other outcomes

  1. Score in the Raven's Progressive Matrices test

    The Raven's Progressive Matrices test is used to measure the level of general intelligence, understood as fluid intelligence. It is scored on a scale from 0 to 60, with higher scores indicating better outcome.

    Time frame: 45 minutes after the first dose of supplementation with Hericium erinaceus extract or placebo.

  2. Score in Adherence to the Mediterranean diet

    The scale ranges from 0 to 7, with higher scores reflecting greater adherence to the Mediterranean diet.

    Time frame: 45 minutes after the first dose of supplementation with Hericium erinaceus extract or placebo.

07

Study locations

1 site
  • SWPS University
    Warsaw, Masovian Voivodeship 03-815, Poland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07405632
Lead sponsor
University of Social Sciences and Humanities, Warsaw
Collaborators
Omyu Sp. z o.o., SWPS University Doctoral School
Responsible party
Maria Kossowska (Msc, University of Social Sciences and Humanities, Warsaw) — Principal investigator
First posted
Feb 12, 2026
Start date
Jan 13, 2025
Primary completion
Oct 11, 2025
Completion
Oct 11, 2025
Last update
Feb 12, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion